FDA Approves Cyclosporine Ophthalmic Ointment for Dogs with Chronic Keratoconjunctivitis Sicca

Summary

The FDA is amending animal drug regulations to reflect approval of a new animal drug application filed by Schering-Plough Animal Health Corp. for the treatment of chronic keratoconjunctivitis sicca in dogs using cyclosporine ophthalmic ointment.